Nevada Initiative to Reduce Long-Term Foster Care

March 22, 2019 updated by: Westat

Permanency Innovations Initiative- Nevada Initiative to Reduce Long-Term Foster Care

The evaluation of the Nevada Initiative to Reduce Long-Term Foster Care (LTFC) includes three populations. It will examine how the interventions SAFE- FC and FSE impact or relate to permanency outcomes for children most at risk for long term foster care and currently in care.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The project targets three populations of children. For populations 1 and 2, the study will evaluate an intervention known as SAFE-FC. The intervention aims to prevent long term foster care by providing tailored services and intensive engagement with all new families with children identified as unsafe (Population 1) and for cases that are currently in care and at risk of LTFC where reunification is the case goal (Population 2). Family Search and Engagement (FSE) is the intervention for Population 3; it involves intense search practices to identify possible permanency resources. For Populations 1 and 2 the study is a randomized, intent-to-treat design to measure safety and permanency outcomes. For Population 3 the evaluation will be a descriptive study to analyze relationships between the intervention approach and outcomes. Both studies aim to examine how the interventions (SAFE- FC and FSE) impact or relate to permanency outcomes for children most at risk for long term foster care.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
507

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

No older than 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Children assessed to be unsafe via the Nevada Initial Assessment
  • children in foster care with specific risk characteristics.

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Treatment
Other: SAFE FC
SAFE - FC, a combination of SAFE (developed by ACTION for Child Protection) and Family Connections (developed by Ruth H. Young Center for Families and Children, University of Maryland School of Social Work) for Populations 1 and 2.
Other Names:
  • SAFE - FC, a combination of SAFE and Family Connections
No Intervention: Comparison

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Time to stable permanence
Time Frame: Measured from the date of random assignment to the discharge date or to the end of the study period for cases that did not discharge
Measured by administrative data from the Adoption and Foster Care Analysis and Reporting System (AFCARS)
Measured from the date of random assignment to the discharge date or to the end of the study period for cases that did not discharge
Caregiver readiness for change
Time Frame: Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
Measured with Readiness for Parenting Change Scale (REDI) Abbreviated (Chaffin et al, 2011)
Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Caregiver stress
Time Frame: Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
Parenting Stress Index - Short Form (PSI-SF) (Abidin, 1983)
Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)

Other Outcome Measures

Other Outcome Measures

For clinical trials, a planned measurement described in the protocol that is used to determine the effect of an intervention/treatment on participants. For observational studies, a measurement or observation that is used to describe patterns of diseases or traits, or associations with exposures, risk factors, or treatment. Types of outcome measures include primary outcome measure and secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Caregiver mental health
Time Frame: Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
Brief Symptoms Inventory (BSI) (Derogatis, 1993)
Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
Child behavior/mental health problems
Time Frame: Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
Child Behavior Checklist (CBCL) (Achenbach, 1991)
Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
Positive parenting attitudes
Time Frame: Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
Adult-Adolescent Parenting Inventory (AAPI-2) (Bavolek & Keene, 1999)
Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
Social support
Time Frame: Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
Social Provisions Scale (SPS) (Russell & Cutrona, 1984)
Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
Helping alliance for both caregiver and worker
Time Frame: Measured at 6 months and again at case closure (duration of their involvement with Washoe County DSS is on average 24 months)
Helping Relationship Inventory (Poulin & Young, 1997)
Measured at 6 months and again at case closure (duration of their involvement with Washoe County DSS is on average 24 months)
Resiliency
Time Frame: Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
Resiliency Attitudes Scale (RAS) (Briscoe, B. & Harris, B., 1994)
Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
Home stability
Time Frame: Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
Based on subscales of the CWBS (questions from Zuravin & DePanfilis, 1996)
Measured at intake, at 6 months, 12 months, 18 months, and again at case closure (participants will be followed throughout the duration of their involvement with Washoe County DSS which is on average 24 months)
Time to permanency
Time Frame: Measured every six months in calendar year
State administrative data system
Measured every six months in calendar year
Recurrence of child abuse and neglect
Time Frame: Measured every six months in calendar year
State administrative data system
Measured every six months in calendar year
Placement rate (population 1 only)
Time Frame: Measured every six months in calendar year
State administrative data system
Measured every six months in calendar year
Time for case closure
Time Frame: Measured every six months in calendar year
State administrative data system
Measured every six months in calendar year
Time to reunification
Time Frame: Measured every six months in calendar year
State administrative data system
Measured every six months in calendar year
Foster care re entry rate
Time Frame: Measured every six months in calendar year
State administrative data system
Measured every six months in calendar year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Westat

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
Children's Bureau - Administration for Children and Families

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
September 1, 2010

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 1, 2015

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 1, 2015

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
June 17, 2014

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 23, 2014

First Posted (Estimate)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
June 24, 2014

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
March 26, 2019

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 22, 2019

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
March 1, 2019

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 8977-2

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings